i've stopped losing weight on semaglutide Many Patients Maintain Loss a Year After Stopping and Liraglutide What happens when you stop

1 Introduction According to the International Diabetes Federation, the global population with diabetes reached 537 million by 2021, with 90% of cases attributed to type 2 diabetes (T2DM) ( In recent years, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have gained attention not only for their role in glycemic control in T2DM but also for their potential in weight management

In the past decade, peptidomimetics have gained recognition as valuable bioactive agents and promising drug candidates, especially in the area of targeting and modulating proteinprotein interactions

The Oncologist

O crescente interesse do setor farmacutico por terapias baseadas em GLP-1 reflete tanto a eficcia clnica quanto a oportunidade mercadolgica